ANTIOXIDATIVE THERAPEUTIC STRATEGIES FOR PARKINSONS-DISEASE

被引：10

作者：

SHOULSON, I ^{[1
]}

机构：

[1] UNIV ROCHESTER, MED CTR, DEPT PHARMACOL, ROCHESTER, NY 14642 USA

来源：

ANNALS OF THE NEW YORK ACADEMY OF SCIENCES | 1992年 / 648卷

关键词：

D O I：

10.1111/j.1749-6632.1992.tb24522.x

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

[No abstract available]

引用

页码：37 / 41

页数：5

共 22 条

[1] INCREASED LIFE EXPECTANCY RESULTING FROM ADDITION OF L-DEPRENYL TO MADOPAR TREATMENT IN PARKINSONS-DISEASE - A LONGTERM STUDY [J].

BIRKMAYER, W ;

KNOLL, J ;

RIEDERER, P ;

YOUDIM, MBH ;

HARS, V ;

MARTON, J .

JOURNAL OF NEURAL TRANSMISSION, 1985, 64 (02) :113-127

[2]

CHRISP P, 1991, Drugs and Aging, V1, P228, DOI 10.2165/00002512-199101030-00006

[3] DEPRENYL SUPPRESSES THE OXIDANT STRESS ASSOCIATED WITH INCREASED DOPAMINE TURNOVER [J].

COHEN, G ;

SPINA, MB .

ANNALS OF NEUROLOGY, 1989, 26 (05) :689-690

[4]

Csanda E, 1987, J Neural Transm Suppl, V25, P105

[5] DEPRENYL IN PARKINSON DISEASE [J].

EISLER, T ;

TERAVAINEN, H ;

NELSON, R ;

KREBS, H ;

WEISE, V ;

LAKE, CR ;

EBERT, MH ;

WHETZEL, N ;

MURPHY, DL ;

KOPIN, IJ ;

CALNE, DB .

NEUROLOGY, 1981, 31 (01) :19-23

[6] SELEGILINE USE TO PREVENT PROGRESSION OF PARKINSONS-DISEASE - EXPERIENCE IN 22 DENOVO PATIENTS [J].

ELIZAN, TS ;

YAHR, MD ;

MOROS, DA ;

MENDOZA, MR ;

PANG, S ;

BODIAN, CA .

ARCHIVES OF NEUROLOGY, 1989, 46 (12) :1275-1279

[7]

FAHN S, 1989, ANN NY ACAD SCI, V570, P186

[8] N-METHYL-D-ASPARTATE ANTAGONISTS IN THE TREATMENT OF PARKINSONS-DISEASE [J].

GREENAMYRE, JT ;

OBRIEN, CF .

ARCHIVES OF NEUROLOGY, 1991, 48 (09) :977-981

[9]

HOLFORD NHG, 1991, CLIN PHARMACOL THER, V49, P152

[10] THE AMPA RECEPTOR ANTAGONIST NBQX HAS ANTIPARKINSONIAN EFFECTS IN MONOAMINE-DEPLETED RATS AND MPTP-TREATED MONKEYS [J].

KLOCKGETHER, T ;

TURSKI, L ;

HONORE, T ;

ZHANG, ZM ;

GASH, DM ;

KURLAN, R ;

GREENAMYRE, JT .

ANNALS OF NEUROLOGY, 1991, 30 (05) :717-723

← 1 2 3 →